Growing community of inventors

New Brunswick, NJ, United States of America

Li Tao

Average Co-Inventor Count = 8.00

ph-index = 5

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 64

Li Tao ↔ Prakash V Parab (5 patents)Li Tao ↔ Mandar V Dali (5 patents)Li Tao ↔ Ravindra W Tejwani (5 patents)Li Tao ↔ Jatin M Patel (5 patents)Li Tao ↔ Dilbir S Bindra (5 patents)Li Tao ↔ Nipa Vatsaraj (5 patents)Li Tao ↔ Yongmei Wu (5 patents)Li Tao ↔ Yongemei Wu (1 patent)Li Tao ↔ Yongmei Wu (1 patent)Li TaoLi Tao (5 patents)Prakash V ParabPrakash V Parab (18 patents)Mandar V DaliMandar V Dali (14 patents)Ravindra W TejwaniRavindra W Tejwani (11 patents)Jatin M PatelJatin M Patel (10 patents)Dilbir S BindraDilbir S Bindra (7 patents)Nipa VatsarajNipa Vatsaraj (5 patents)Yongmei WuYongmei Wu (5 patents)Yongemei WuYongemei Wu (2 patents)Yongmei WuYongmei Wu (1 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Bristol-myers Squibb Compnay (4 from 3,681 patents)

2. Astrazeneca Ab (1 from 1,500 patents)


5 patents:

1. 9198925 - Pharmaceutical formulations containing an SGLT2 inhibitor

2. 8716251 - Pharmaceutical formulations containing an SGLT2 inhibitor

3. 8361972 - Pharmaceutical formulations containing an SGLT2 inhibitor

4. 8221786 - Pharmaceutical formulations containing an SGLT2 inhibitor

5. 7851502 - Pharmaceutical formulations containing an SGLT2 inhibitor

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/4/2025
Loading…